熱門資訊> 正文

Climb Bio通过私募融资1.1亿美元;股价上涨

2026-04-28 21:03

Climb Bio(CLYM) 0

Climb Bio (CLYM) agreed to raise ~$110M via a private placement with institutional investors.
The offering includes 9.48M shares priced at $9.50 per share.
Investors will also receive pre-funded warrants for up to 2.11M shares.
Pre-funded warrants are priced at $9.4999 with a $0.0001 exercise price.
The transaction is expected to close around April 29, 2026.
CLYM shares up 8% premarket.

More on Climb Bio

Climb Bio: 'Buy' On Budoprutug Phase 2 Advancement pMN And Expansions Underway
Climb Bio GAAP EPS of -$0.26
Cheap high flyer healthcare stocks - high momentum and low valuation
Seeking Alpha’s Quant Rating on Climb Bio
Historical earnings data for Climb Bio

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。